Clinical Trials

Our Clinical Trials articles highlight top clinical trials, their results, and how patients can participate in them.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

First R/R Myeloma Patient Treated with New BCMA-Directed Bispecific Antibody in Phase 3 Study

June 21, 2024

Learn about a new BCMA-directed bispecific antibody called ABBV-383, administered to relapsed/refractory myeloma patients in a clinical trial.

The Use of Bispecifics and CAR-T in Myeloma Treatment

May 21, 2024

The Use of Bispecifics And CAR-T In Myeloma Treatment

Ensuring Access to Myeloma Research, with Dr. Gurbakhash Kaur

May 07, 2024

Watch our interview with Dr. Kaur. She shared the comprehensive myeloma research program at UT Southwestern.

ORIC-533 : A New Small Molecule to Treat Multiple Myeloma

April 26, 2024

Learn about ORIC-533, a potential new oral treatment for myeloma. Understand how it works, early clinical trial results, and the future outlook for this drug.

How CAR-T Therapy is Changing the Treatment Landscape for Myeloma

April 18, 2024

Simmons Cancer Center leads Myeloma research with CAR-T, stem cells & more. Learn about GPRC5D targeting, Tregs, bispecific antibodies & upcoming trials.

ASH 2023: Understanding Outcomes of CAR T in Extramedullary Multiple Myeloma

January 18, 2024

What are the outcomes following CAR T-cell therapy in multiple myeloma patients with extramedullary and paramedullary disease?

LBL-034: A New Option for Myeloma Patients in Clincal Trial Stage

August 24, 2023

Nanjing Leads Biolabs is starting a new clinical trial for a myeloma bi-specific antibody targeting GPRC5D.

Boosting Quality of Life and Immune Function with Non-Chemotherapy Interventions for Multiple Myeloma

July 25, 2023

Roswell Park Cancer Institute investigates changes in myeloma patients' immune cell subsets after non-chemo interventions.

Reversing T-cell Exhaustion with Antioxidants

June 13, 2023

Dr. Gunjan L. Shah and her team at MSK in NY are conducting a clinical trial to reverse T-cell exhaustion by pairing antioxidants alongside CAR T-cell therapy.

Clinical Trial: Boosting Quality of Life and Immune Function with Non-Chemotherapy Approaches for Multiple Myeloma

May 21, 2023

The main goal of the study is to find out if non-chemotherapeutic interventions can improve the immune system and quality of life in people with myeloma.